| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mohan Jitendra | Chief Executive Officer, Director | C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE | /s/ Philip Mazzara, Attorney-in-Fact | 2025-08-11 | 0001998053 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -0.59% | $170.33 | 4.28M | Aug 7, 2025 | By Living Trust | F1, F2, F3, F4 |
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -3.5% | $170.33 | 700K | Aug 7, 2025 | By Trust | F1, F2, F3, F5 |
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -3.5% | $170.33 | 700K | Aug 7, 2025 | By 2021 Trust 1 | F1, F2, F3, F6 |
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -3.5% | $170.33 | 700K | Aug 7, 2025 | By 2021 Trust 2 | F1, F2, F3, F7 |
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -5.35% | $170.33 | 450K | Aug 7, 2025 | By 2022 Trust 1 | F1, F2, F3, F8 |
| transaction | ALAB | Common Stock | Sale | -$4.33M | -25.4K | -5.35% | $170.33 | 450K | Aug 7, 2025 | By 2022 Trust 2 | F1, F2, F3, F9 |
| holding | ALAB | Common Stock | 2.26M | Aug 7, 2025 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. |
| F2 | The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. |
| F3 | (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |
| F4 | These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F5 | These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F6 | These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F7 | These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F8 | These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F9 | These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |